Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Murley

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Oncology|December 6, 2002
Radioprotectants: current status and new directionsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka
Radiation Research|April 24, 2014
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugsRichard C Miller, Jeffrey S Murley, David J Grdina
Military Medicine|March 5, 2002
Relationships between cytoprotection and mutation prevention by WR-1065David J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Seminars in Radiation Oncology|March 28, 2002
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cellsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Radiation Research|August 29, 2007
Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugsYasushi Kataoka, Jeffrey S Murley, Kenneth L Baker, et al.
Radiation Research|August 17, 2017
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive ResponseJeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, et al.
Free Radical Biology & Medicine|April 17, 2018
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive responseJeffrey S Murley, Jack L Arbiser, Ralph R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC)Nikolai N Khodarev, Yasushi Kataoka, Jeffrey S Murley, et al.
Free Radical Biology & Medicine|March 17, 2006
Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065Jeffrey S Murley, Yasushi Kataoka, Christine J Weydert, et al.
Journal of Radiation Research|September 9, 2006
Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cellsYasushi Kataoka, Vytautas P Bindokas, Ryan C Duggan, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Oncology|December 6, 2002
Radioprotectants: current status and new directionsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka
Radiation Research|April 24, 2014
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugsRichard C Miller, Jeffrey S Murley, David J Grdina
Military Medicine|March 5, 2002
Relationships between cytoprotection and mutation prevention by WR-1065David J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Seminars in Radiation Oncology|March 28, 2002
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cellsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Radiation Research|August 29, 2007
Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugsYasushi Kataoka, Jeffrey S Murley, Kenneth L Baker, et al.
Radiation Research|August 17, 2017
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive ResponseJeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, et al.
Free Radical Biology & Medicine|April 17, 2018
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive responseJeffrey S Murley, Jack L Arbiser, Ralph R Weichselbaum, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC)Nikolai N Khodarev, Yasushi Kataoka, Jeffrey S Murley, et al.
Free Radical Biology & Medicine|March 17, 2006
Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065Jeffrey S Murley, Yasushi Kataoka, Christine J Weydert, et al.
Journal of Radiation Research|September 9, 2006
Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cellsYasushi Kataoka, Vytautas P Bindokas, Ryan C Duggan, et al.
Pageof 4